The restructuring events database contains factsheets with data on large-scale restructuring events reported in the principal national media and company websites in each EU Member State. This database was created in 2002.
Palafolls, Castellano de Moriscos, Almunia de Doña Godina
Sector
Manufacturing (20 - 21) Manufacture of chemicals and pharmaceuticals 21 - Manufacture of basic pharmaceutical products and pharmaceutical preparations 21.2 - Manufacture of pharmaceutical preparations
124 jobs Number of planned job creations
Announcement Date
6 September 2022
Employment effect (start)
6 September 2022
Foreseen end date
6 September 2024
Description
Novartis is a Swiss multinational in the manufacture of pharmaceutical products sector. The company has announced an investment of more than 75 million euros by 2024 to improve the production and innovation capacity of its factories in Spain, with a total net employment creation of 124 new jobs. In particular, the company is expecting to invest more than 63 million euros in its Palafolls factory (Barcelona) to convert it into one of the company's two innovative antibiotic production centres in Europe. 84 new jobs will be created and the manufacturing capacity of the facility will increase by 150%, from 200 to 500 tonnes per year.
In the field of nuclear medicine, Novartis will invest 12.9 million euros in an innovative facility in Castellanos de Moriscos (Salamanca) for the production of radioligands, which are medicines already used for the treatment of breast and prostate tumours, among others. The new factory will create at least 20 jobs.
Lastly, Novartis will also invest a further 1.5 million euros in the expansion of its plant in Almunia de Doña Godina (Zaragoza), which will multiply production capacity by five, double export capacity and create another 20 new jobs.
Currently, Novartis employs 2,037 people in Spain.
Eurofound (2022), Novartis, Business expansion in Spain, factsheet number 107408, European Restructuring Monitor. Dublin, https://apps.eurofound.europa.eu/restructuring-events/detail/107408.
Eurofound’s ERM restructuring legislation database offers an overview of key restructuring-related regulations in the EU Member States and Norway. Its content is continuously updated to reflect any changes made by national legislators in response to, for instance, policy shifts, legal...
Can Europe still achieve its ambitions for battery manufacturing? To answer this, the article looks at data from Eurofound’s European Restructuring Monitor and explores what recent large-scale restructuring events reveal about the state of play in the EU battery sector.
This working paper offers a comprehensive methodological overview of the European Restructuring Monitor (ERM) databases. Even though the methodology has not changed over time, new categories have been added, and the way it has been used by researchers and policymakers...
This Eurofound research paper explores key trends in restructuring in recent years, highlighting the companies that announced the largest job losses and job gains in the EU. It builds on an analysis of company announcements recorded in Eurofound’s European Restructuring...
In 2023, thousands of workers in big tech lost their jobs. Meta, Amazon, Google, Apple, Microsoft and Salesforce had been considered to offer good and secure jobs up to this point. Giants of the information and communication technology (ICT) sector,...
In 2024, the automotive sector in the EU came to the fore in public and policy discussions. The focus was on the slowdown in electric vehicle (EV) sales, rising global competition, belated investments in new technologies, and the potential closure...